Allergy/Asthma News

Physicians should consider the overall clinical impression instead of focusing on individual signs and symptoms to diagnose acute rhinosinusitis, according to a study published in the Annals of Family Medicine.

Women who took high doses of vitamin D supplementation during pregnancy did not impact their child’s risk for asthma by the age of 6 years, according to data recently published in JAMA.

Faced with an increasing incidence and prevalence of autoimmune disease in the United States —approximately 23.5 million Americans are affected across the country, according to the NIH — Bonnie Feldman, MBA, DDS, says it is time to acknowledge what she calls “an invisible epidemic.”

Regeneron Pharmaceuticals and Sanofi announced that the FDA has approved Dupixent for patients aged 12 to 17 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled by topical prescriptions or when those therapies are not advisable.

Patients with severe chronic rhinosinusitis with nasal polyps treated with Dupixent showed improvements in nasal polyp size, nasal congestion severity, chronic sinus disease, sense of smell and comorbid asthma outcomes, according to data presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.

New research on food allergy treatments, stewardship of oral corticosteroids, microbiome’s role in allergy development, and shared decision making were some of the highlights at the recent American Academy of Allergy, Asthma and Immunology annual meeting. 

Children delivered by cesarean were more likely to have milk allergy and GERD, according to findings presented at the American Academy of Allergy, Asthma and Immunology.

Although children with and without atopic dermatitis receive a comparable amount of sleep, children with the condition are more likely to have a reduced quality of sleep, regardless of the severity of disease.

The prevalence of asthma was higher among patients with opioid dependence, according to findings presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.

The Viaskin peanut patch was well-tolerated and safe for young children with a peanut allergy, according to findings presented at the American Academy of Allergy Asthma and Immunology annual meeting.